Jena, July 28, 2010 — Analytik Jena AG (Frankfurt DE0005213508, Prime Standard: AJA) today announced its preliminary sales and earnings figures for the first nine months of the current 2009/2010 financial year. The Thuringia-based provider of analytical instrumentation technology generated an operating result (EBIT) of EUR 3.2 m on the back of sales of EUR 59.6 m. Earnings per share amounted to EUR 0.47.

Based on the current course of business, the Company expects to record EBIT of around EUR 5.0 m and earnings per share of around EUR 0.60 for the financial year as a whole, down on its initial forecasts.

This adjustment is due to the sustained difficult development in the Optics segment, which has not enjoyed the recovery that was expected. The Company also reported non-recurring effects from the closure of CyBio Japan in the past quarter, as well as a sharp increase in costs for the establishment of a uniform international sales structure in the Life Science sector.

The Company still expects to achieve record sales of around EUR 80.0 m and intends to recommend the distribution of a dividend to the Supervisory Board at its meeting in December 2010 to adopt the annual financial statements.

This information is based on preliminary key financial figures. The complete figures for the first nine months of the 2009/2010 financial year will be announced on August 12, 2010.

Contact:
Dana Schmidt
Analytik Jena AG
Konrad-Zuse-Strasse 1
07745 Jena | Germany
Phone: +49 (0) 36 41  77-92 81
E-mail: ir@analytik-jena.com

Jena, June 30, 2010 — Analytik Jena AG has received an extensive new order from Poland. The system provider of analytic measurement technology headquartered in Jena, Germany, is delivering a total of 20 TOC analyzers to the Polish Inspectorate of Environmental Protection (GIOS) as well as their regional investigations offices. The company was therefore able to further strengthen its market position in the neighboring country.

The project was acquired by marketing partner Meranco in Poznan, Poland, which has successfully been acting as an exclusive distributor for the business unit of Analytical Instrumentation in this region for many years.

"This project is a great success for Analytik Jena. We are able to further expand our position as a provider of high-quality analytic measurement instruments in Poland and secure important competitive advantages," said Klaus Berka, CEO of Analytik Jena AG.

The TOC analyzer is an instrument for measuring the total organic carbon content in aqueous and solid samples. The technology is used for determining the water quality in lakes, rivers and waste waters. The area of environmental analysis is a globally growing market determined by international and national regulations. The analysis of total organic carbon (TOC) is an important parameter in this process.

"With increasing general conditions in the area of environmental protection and the related area of resource management, the requirements on appropriate technology for analysis of this sector are increasing as well. This project clearly shows that the products of Analytik Jena are recognized as excellent technologies, particularly in the public authority segment abroad," said Torsten Olschewski, Sales and Marketing Director in the Analytical Instrumentation business unit at Analytik Jena.

The project is part of the program for the regional development of Poland, co-financed by the European Union. The goal is to optimize the handling of existing resources and to avert environmental risks.

Jena, June 21, 2010 – With the integration of the sales unit of CyBio Japan Co. into Analytik Jena AG's Japanese subsidiary, the Jena-based systems provider for analytical instrumentation technology is bundling its sales competence in one of the biggest and most dynamic markets in this segment. At the dealer conference organized by Analytik Jena in Yokohama, Japan, on May 28, 2010, the company launched the joint Group-wide market campaign.

"Our goal is to further expand Analytik Jena's international network and to exploit the experience and structures of the successful Analytical Instrumentation division for other business units and subsidiaries too", said Klaus Berka, CEO of Analytik Jena AG. "Thanks to the extensive synergies resulting from bundling sales structures and expertise in the Group, we will be able to achieve significant sales and growth potential."

With an export ratio of nearly 70% and a distinctive international retailer network, Analytik Jena now operates in more than 90 countries worldwide. In the past fiscal year, the Group generated sales of close to EUR 50 million outside Germany.

"The Japanese market for analytical instrumentation technology is the third biggest in the world and will develop rapidly. Many governments in the Far East have invested considerable sums in biological and pharmaceutical research and established related programs", stressed Torsten Olschewski, head of sales and marketing in the Analytical Instrumentation division at Analytik Jena. "In the atomic spectroscopy and elemental analysis product lines, we will position ourselves even more broadly with additional products and will benefit in particular from our good reputation in Asia."

A total of 62 Japanese retailers participated in the conference in Yokohama. The event focused on the development and consolidation of the Life Science division and in particular on the integration of CyBio, which caters to a specific industry with the major pharmaceutical groups, into the existing sales activities.

"The pharmaceuticals market has been undergoing a dramatic change in recent years. Now we must push forward CyBio's international business with high-quality, innovative products and the right market strategy", said Berka.

Photos are available at
http://www.analytik-jena.com/en/site/Press-Center/Downloads__3885/

Jena, June 15, 2010 – Analytik Jena AG and SIRS-Lab GmbH, also based in Jena, will be strengthened by working together in the field of molecular sepsis diagnostics. As part of this cooperation, Analytik Jena subsidiary AJ Innuscreen GmbH will provide the partner with a platform for automated isolation of nucleic acids with the associated reagent system worth almost half a million euro.

“In the field of sepsis diagnostics, speed plays a vital role in identifying infections and detecting pathogens. Analytik Jena's cooperation with SIRS-Lab offers great potential for the challenging area of diagnostics”, commented Klaus Berka, CEO of Analytik Jena AG.

SIRS-Lab is a Jena-based biotechnology company which develops and produces test systems for molecular diagnosis of life-threatening infections. SIRS-Lab is a member of the German Sepsis Society and works with many internationally recognized partners. One significant partner is the university hospital of the Friedrich Schiller University of Jena, which in January 2010 received the green light from an international jury of experts to develop an integrated research and treatment center for sepsis and related illnesses. This development is focused primarily on enabling rapid and targeted antibiotic therapy for sepsis.

“Analytik Jena provides us with special reagents and instruments, tailored to our developments, for the fully automated extraction of DNA in whole blood samples. The clinical studies currently underway to validate the test should create the conditions to start marketing our sepsis diagnostics very soon”, explained Barbara Staehelin, CEO of SIRS-Lab GmbH.

Analytik Jena AG concentrates its biotechnological expertise in the Life Science division. Its service includes automated individual and complete solutions for molecular diagnostics. The wide range of products is made possible by synergies between Analytik Jena and its subsidiaries AJ Cybertron, AJ Innuscreen, AJ Roboscreen, AJ eBiochip, CyBio AG and Biometra GmbH. AJ Innuscreen, headquartered in Berlin, was founded in 2005 for the development and manufacture of kits for molecular diagnostics.

Jena, June 11, 2010 — Dr. Gerhard Schlemmer, head of the Research and Development division at Analytik Jena AG, has been presented with the Ioannes Marcus Marci Medal for outstanding developments in the field of atomic spectroscopy. The prestigious prize is awarded every two years by the Czech-Slovak Spectroscopic Society, which met from May 31 to June 3 in Litomysl, Czech Republic

"Naturally, Analytik Jena pays special recognition to the services of Dr. Schlemmer with pride and pleasure. For many years, Dr. Schlemmer has performed exceptional work in the research and development of analytical instrumentation technology at Analytik Jena. He has made a crucial contribution to ensuring that in the unique contrAA^® technology, the company offers a product with the utmost innovation in the field of atomic absorption spectrometry. This remains an important unique selling proposition and a significant guarantee of sales for the company in a fiercely competitive global market", commented Klaus Berka, CEO of Analytik Jena AG

When it was introduced in 2004, contrAA^® technology revolutionized the whole field of atomic absorption spectrometry, enabling the entire periodic table to be analyzed using a single radiation source. contrAA^® remains the flagship product of Analytik Jena

Schlemmer, 58, has been an analytical chemist and spectroscopist for 30 years. He has been responsible for research and development at Analytik Jena since summer 2004, having joined the company in 2002

A photo of Dr. Schlemmer is available at
http://www.analytik-jena.de/en/site/Pressezentrum/Downloads__3885/.

Jena, June 1, 2010 — The prosecution Erfurt today as part of an investigation of tax offenses in Thuringia also confiscated documents of the AJZ Engineering GmbH. Subject of the investigation concerning AJZ Engineering GmbH are payments made to foreign service providers shown in the accounts of the Company in connection with different foreign projects. AJZ Engineering GmbH offers system solutions for projects in research and teaching, medicine, life science and industry. Analytik Jena AG (Frankfurt DE0005213508, Prime Standard: AJA) holds a minority stake of 49 percent in AJZ Engineering GmbH.

Analytik Jena AG itself is not focus of the prosecution, but is indirectly affected due to the profit transfer agreement that existed until early 2008. In view of this, Analytik Jena AG is interested in an expeditious completion of the investigations.

AJZ Engineering GmbH will fully cooperate with the authorities and do everything to contribute to the clarification of the facts. AJZ Engineering GmbH understands that the accusations are groundless.

Because of the ongoing proceedings, a further statement on the facts or individual allegations is currently not possible.

Contact:
Dana Schmidt
Analytik Jena AG
Konrad-Zuse-Strasse 1
07745 Jena | Germany
Phone: +49 (0) 36 41  77-92 81
E-mail: ir@analytik-jena.com